Does donor kidney to recipient body weight ratio influence long-term outcomes of living-donor kidney transplantation?

Transplant Proc. 2012 Jan;44(1):276-80. doi: 10.1016/j.transproceed.2011.12.005.

Abstract

This study evaluated the effect of the donor kidney to recipient body weight (Kw/Rw) ratio on long-term graft function and survival. We investigated retrospectively whether there was any association between Kw/Rw ratio and long-term graft survival and function after a follow-up of >10 years. We studied a consecutive series of 123 adult-to-adult living kidney transplants. According to the Kw/Rw ratio, patients were divided into 3 groups: "low" (Kw/Rw <2.85; n = 29), "medium" (2.85 ≤ Kw/Rw < 4.04; n = 63), and "high" (≥4.04; n = 31). Among the 3 groups, the mean serum creatinine levels at 1 and 6 months as well as 1 year after transplantation were significantly lower among patients with a high Kw/Rw ratio than in those with a medium or low ratio, but serum creatinine levels at 3 and 5 years did not differ significantly (P = .394 and 0.620, respectively). Graft survival rates at 5 and 10 years after transplantation were significantly lower in the "low" group. We observed a significant association between Kw/Rw ratio and graft survival (P = .018). The Kw/Rw ratio is an important factor for long-term graft survival and early graft function. However, it did not significantly affect subsequent renal function.

MeSH terms

  • Adult
  • Biomarkers / blood
  • Body Weight*
  • Creatinine / blood
  • Female
  • Graft Rejection / blood
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Graft Survival / drug effects
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kaplan-Meier Estimate
  • Kidney / anatomy & histology
  • Kidney / surgery*
  • Kidney Diseases / blood
  • Kidney Diseases / etiology
  • Kidney Transplantation* / adverse effects
  • Kidney Transplantation* / immunology
  • Living Donors*
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Organ Size
  • Proportional Hazards Models
  • Registries
  • Republic of Korea
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Immunosuppressive Agents
  • Creatinine